Literature DB >> 23053335

[Conspicuous crystalline lens foreign body after intravitreal injection].

S Koller1, T Neuhann, I Neuhann.   

Abstract

In January 2011 a 63-year-old woman with retinal branch vein occlusion and a macular edema first presented with a conspicuous foreign body of the crystalline lens. The rare event of an inadvertently into the lens placed Ozurdex® was diagnosed. Due to recurrent macular edema several reinjections of Ozurdex® were necessary. Phacoemulsification was performed 11 months later for advanced cataract formation. An uncomplicated fixation of the intraocular lens (IOL) into the capsular bag was enabled due to fibrosis of the capsular defect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053335     DOI: 10.1007/s00347-012-2650-8

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  5 in total

1.  Incidence of damage to the crystalline lens during intravitreal injections.

Authors:  Carsten H Meyer; Eduardo B Rodrigues; Stephan Michels; Stefan Mennel; Jörg C Schmidt; Hans-Martin Helb; Annette Hager; Mauricio Martinazzo; Michel E Farah
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

2.  Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections.

Authors:  Carsten H Meyer; Stephan Michels; Eduardo B Rodrigues; Annette Hager; Stefan Mennel; Jörg C Schmidt; Hans-Martin Helb; Michel E Farah
Journal:  Acta Ophthalmol       Date:  2010-12-22       Impact factor: 3.761

3.  The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

Authors:  A E Fung; P J Rosenfeld; E Reichel
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

Review 4.  Management of posterior capsule tears.

Authors:  R B Vajpayee; N Sharma; T Dada; V Gupta; A Kumar; V K Dada
Journal:  Surv Ophthalmol       Date:  2001 May-Jun       Impact factor: 6.048

5.  Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis.

Authors:  Ludimila L Cavalcante; Milena L Cavalcante; Timothy G Murray; Michael M Vigoda; Yolanda Piña; Christina L Decatur; R Prince Davis; Lisa C Olmos; Amy C Schefler; Michael B Parrott; Kyle J Alliman; Harry W Flynn; Andrew A Moshfeghi
Journal:  Clin Ophthalmol       Date:  2010-05-25
  5 in total
  5 in total

1.  Intralenticular Ozurdex® - One Year Later.

Authors:  Kathleen A Regan; Charles R Blake; Zachary L Lukowski; Siva S R Iyer
Journal:  Case Rep Ophthalmol       Date:  2017-12-21

2.  [Reliability and safety of intravitreal Ozurdex injections. The ZERO study].

Authors:  K Schmitz; M Maier; C R Clemens; F Höhn; J Wachtlin; F Lehmann; T Bertelmann; K Rüdiger; M Horn; A Bezatis; G Spital; C H Meyer
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

3.  Inadvertent steroid injection into the crystalline lens.

Authors:  Md Shahid Alam; Vikas Khetan
Journal:  GMS Ophthalmol Cases       Date:  2017-06-27

4.  Inadvertent intralenticular dexamethasone implant: 1-year follow-up and management.

Authors:  Cagatay Caglar
Journal:  Oman J Ophthalmol       Date:  2017 Sep-Dec

5.  Iatrogenic crystalline lens injury during intravitreal injection of triamcinolone acetonide: A report of two cases.

Authors:  Jing Su; Li-Jun Zheng; Xin-Quan Liu
Journal:  World J Clin Cases       Date:  2019-11-26       Impact factor: 1.337

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.